Galacto-oligosaccharide Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Clasado Biosciences and Fonterra Co operative Group Ltd. | Technavio

Technavio has announced its latest market research report titled Global Galacto-oligosaccharide Market 2020-2024 (Graphic: Business Wire)

LONDON--()--The global galacto-oligosaccharide market is expected to grow by USD 486.79 million as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, steady growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of almost 10%.

Request challenges and opportunities that influence COVID-19 pandemic - Request Free Sample Report on COVID-19 Impacts

Read the 120-page report with TOC on "Galacto-oligosaccharide Market Analysis Report by Product (Syrup and Powder), Geography (Europe, North America, Asia, and ROW), and the Segment Forecasts, 2020-2024".

The market is driven by the health benefits of galacto-oligosaccharides. In addition, the use of nutraceuticals and prebiotics in treating chronic diseases is anticipated to boost the growth of the galacto-oligosaccharide market.

Galacto-oligosaccharides are prebiotics and non-digestible food ingredients. They stimulate the activity of gut bacteria, which improves immunity, enhance the absorption of essential nutrients, and produce powerful antioxidant H2 gas. Galacto-oligosaccharides also inhibit the binding or survival of opportunistic microorganisms, such as Escherichia coli, Salmonella Typhimurium, and Clostridia. They can also influence the immune system by producing antimicrobial substances and inhibit the growth of pathogenic bacteria. Many such health benefits are fueling the growth of the global galacto-oligosaccharide market.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Galacto-oligosaccharide Companies:

Clasado Biosciences

Clasado Biosciences operates its business through a unified segment. The company offers Bimuno, which is a daily fiber supplement containing galacto-oligosaccharides, which feeds and stimulates the growth of good bacteria in the gut.

Fonterra Co operative Group Ltd.

Fonterra Co operative Group Ltd. operates its business through segments such as Ingredients, Consumer and foodservice, and China Farms. The company offers NZMP SureStart GOS, which is a prebiotic supplement added to infant formula products to make them closer to the composition of breast milk for mothers who cannot or choose not to breastfeed.

Ingredion Inc.

Ingredion Inc. operates its business through segments such as North America, South America, Asia Pacific, and EMEA. The company offers BIOLIGO GL 5700 IMF. It is a soluble dietary fiber made from lactose in the form of a syrup that contains 57% galacto-oligosaccharide.

Lactose (India) Ltd.

Lactose (India) Ltd. operates its business through the Unified segment. The company offers galacto-oligosaccharide produced through the enzymatic conversion of lactose and is available in the powder form.

New Francisco (Yunfu City) Biotechnology Corp. Ltd.

New Francisco (Yunfu City) Biotechnology Corp. Ltd. operates its business through a unified segment. The company offers products such as GOS-270-P, GOS-700-P, and GOS-800-P.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Galacto-oligosaccharide Market Product Outlook (Revenue, USD Million, 2020-2024)

  • Syrup
  • Powder

Galacto-oligosaccharide Market Geography Outlook (Revenue, USD Million, 2020-2024)

  • Europe
  • North America
  • Asia
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Request a free sample report

Related Reports on Healthcare Include:

Global Monoclonal Antibodies Market – Global monoclonal antibodies market by application (oncology, autoimmune disorders, infectious diseases, and other applications), type (murine antibodies, human antibodies, humanized antibodies, and chimeric antibodies), and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200


Release Summary

The Global Galacto-oligosaccharide Market will grow by $ 486.79 mn during 2020-2024


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200